Kyowa Kirin Co.,Ltd. (4151)

Market cap
¥1.26T
P/E ratio
16.7x
Kyowa Kirin manufactures and sells prescription pharmaceuticals through integrated operations from drug development to sales, serving healthcare markets globally.
Period EndNet income (Million JPY)YoY (%)
Dec 31, 202567,040+11.98%
Dec 31, 202459,870-26.26%
Dec 31, 202381,188+51.55%
Dec 31, 202253,573+2.34%
Dec 31, 202152,347+11.31%
Dec 31, 202047,027-29.90%
Dec 31, 201967,084+23.28%
Dec 31, 201854,414+26.84%
Dec 31, 201742,899+129.79%
Dec 31, 201618,669-37.30%
Dec 31, 201529,774+87.28%
Dec 31, 201415,898-47.14%
Dec 31, 201330,078+24.29%
Dec 31, 201224,199-5.50%
Dec 31, 201125,608
AI Chat